Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?
Generic Volar Locking Plate Use in Distal Radius Fractures: A Prospective Randomized Study to Evaluate Clinical Outcomes and Cost Reduction
1 other identifier
interventional
101
1 country
1
Brief Summary
Across orthopedics, the investigators will be using the generic volar locking plates for patients undergoing open reduction and internal fixation (ORIF) of the distal radius using a block schedule, meaning one month we the generic implants and one month we use conventional implants from the surgeon's brand of choice. At the end of each month the health system will switch which type of implants (generic vs. conventional) they will use at their facilities. From a quality perspective each patient will be monitored both short and long term for complication and reoperation. This will be done through chart review.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedFirst Submitted
Initial submission to the registry
March 14, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedResults Posted
Study results publicly available
August 28, 2024
CompletedAugust 28, 2024
March 1, 2024
6 months
March 14, 2024
August 6, 2024
August 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
90-day Reoperation Rate
Reoperation for any reason postoperatively within 90 days after the date of surgery.
Within 90 days postoperatively
90-day Readmission Rate
Readmission to the hospital for any reason postoperatively within 90 days after the date of surgery.
Within 90 days postoperatively
90-day Mortality Rate
Patient death at any point within 90 days after the date of surgery.
Within 90 days postoperatively
Secondary Outcomes (3)
Implant Cost
Day of Surgery
Tourniquet Time
From tourniquet inflation to deflation during the procedure.
Estimated Blood Loss
Day of Surgery
Study Arms (2)
Generic Implant
EXPERIMENTALPatients with an isolated distal radius fracture are treated surgically with a generic volar locking plate. All other surgical protocols remain unchanged.
Conventional Implant
ACTIVE COMPARATORPatients with an isolated distal radius fracture are treated surgically with a conventional, brand name volar locking plate of the surgeon's choice. All other surgical protocols remain unchanged.
Interventions
Application of a generic volar locking plate is done in the generic implant arm compared to the other commonly used implants by surgeons in the conventional implant arm.
Application of a conventional, brand name volar locking plate is done in the conventional implant arm compared to the generic implant arm.
Eligibility Criteria
You may qualify if:
- Isolated distal radius fracture
- Treated surgically with a volar locking plate
You may not qualify if:
- Volar locking plate not used
- Additional fixation was used
- Polytrauma (non-isolated injury)
- Open fracture
- \<18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regions Hospital
Saint Paul, Minnesota, 55101, United States
Related Publications (7)
Walker JA, Althausen PL. Surgeon Attitudes Regarding the Use of Generic Implants: An OTA Survey Study. J Orthop Trauma. 2016 Dec;30 Suppl 5:S27-S31. doi: 10.1097/BOT.0000000000000722.
PMID: 27870671BACKGROUNDWaldrop VH, Laverty DC, Bozic KJ. Value-based Healthcare: Increasing Value by Reducing Implant-related Health Care Costs. Clin Orthop Relat Res. 2019 Feb;477(2):281-283. doi: 10.1097/01.blo.0000534683.24250.9c. No abstract available.
PMID: 29762154BACKGROUNDMiner HR, Slover JD, Koenig KM. Price Transparency and Consumer Perceptions of Generic and Brand-name Implants in Orthopaedic Surgery. Arch Bone Jt Surg. 2022 Sep;10(9):791-797. doi: 10.22038/ABJS.2022.51855.2558.
PMID: 36246025BACKGROUNDMcphillamy A, Gurnea TP, Moody AE, Kurnik CG, Lu M. The Clinical and Economic Impact of Generic Locking Plate Utilization at a Level II Trauma Center. J Orthop Trauma. 2016 Dec;30 Suppl 5:S32-S36. doi: 10.1097/BOT.0000000000000721.
PMID: 27870672BACKGROUNDKhoo KM, Kim GW, Lindvall EM, Martirosian AK. Outcomes and Cost Comparison Between Generic and Conventional Cephalomedullary Nails in the Treatment of Peritrochanteric Femur Fractures. J Am Acad Orthop Surg. 2022 Feb 1;30(3):119-124. doi: 10.5435/JAAOS-D-21-00024.
PMID: 34715691BACKGROUNDDoxey SA, Huyke-Hernandez FA, Robb JL, Bohn DC, Cunningham BP. A Case Series of Surgically Treated Distal Radius Fractures: Implant Costs and Their Effect on Patient Outcomes. J Am Acad Orthop Surg Glob Res Rev. 2023 Jul 7;7(7):e23.00026. doi: 10.5435/JAAOSGlobal-D-23-00026. eCollection 2023 Jul 1.
PMID: 37428150BACKGROUNDDoxey SA, Huyke-Hernandez FA, Robb JL, Bohn DC, Cunningham BP. Implant cost variation in surgically treated distal radius fractures. J Orthop. 2023 Apr 7;39:45-49. doi: 10.1016/j.jor.2023.04.003. eCollection 2023 May.
PMID: 37125012BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Megan Reams; Director of Orthopaedic Research
- Organization
- TRIA Orthopedic Center
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Cunningham, MD
HealthPartners Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients underwent the standard surgical consent, however the specific plate vendor that was used, was not specified by the physician.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2024
First Posted
April 2, 2024
Study Start
November 1, 2022
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
August 28, 2024
Results First Posted
August 28, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
This data will remain confidential and de-identified on our institution's servers.